Epidemiology of gastroesophageal reflux disease in Tehran, Iran

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 9, 2007, Pages 1419-1422

  Ehsani, Mohammad J ^a   Maleki, Iradj ^b,d   Mohammadzadeh, Fatemeh ^a   Mashayekh, Ameneh ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Sina Building ^*  (Iran)

Author keywords

Epidemiology; Gastroesophageal reflux disease; Heartburn; Prevalence

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GASTROESOPHAGEAL REFLUX; GROUPS BY AGE; HEARTBURN; HUMAN; IRAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROBABILITY; RANDOMIZATION; SEX RATIO; SMOKING; SYMPTOM;

EID: 34547971052     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04616.x     Document Type: Article

References (29)

1. Heading RC. Prevalence of upper gastrointestinal symptoms in the general population: a systemic review. Scand. J. Gastroenterol. 1999 (Suppl. 231 3 8.
2. Axon AT. Personal view: to treat or not to treat? Helicobacter pylori and gastro-oesophageal reflux disease - an alternative hypothesis. Aliment Pharmacol. Ther. 2004 19 : 253 61.
3. Pace F, Porro GB. Gastroesophageal reflux disease: a typical spectrum disease (a new conceptual framework is not needed). Am. J. Gastroenterol. 2004 99 : 946 9.
4. Schwenkglenks M, Marbet UA, Szucs TD. Epidemiology and costs of gastroesophageal reflux disease in Switzerland: a population-based study. Soz. Praventivmed. 2004 49 : 51 61.
5. Shammas MA, Koley H, Beer DG, Li C, Goyal RK, Munshi NC. Growth arrest, apoptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telomerase inhibitor. Gastroenterology. 2004 126 : 1337 46.
6. Tutuian R, Castell DO. Gastroesophageal reflux disease: natural history and long-term medical and surgical outcomes. Clin. Cornerstone 2003 5 : 51 60.
7. Spechler SJ. Esophageal complications of gastroesophageal reflux disease: presentation, diagnosis, management, and outcomes. Clin. Cornerstone 2003 5 : 41 50.
8. Soll AH, Fass R. Gastroesophageal reflux disease: presentation and assessment of a common, challenging disorder. Clin. Cornerstone 2003 5 : 2 17.
9. Toruner M, Soykan I, Ensari A, Kuzu I, Yurdaydin C, Ozden A. Barrett's esophagus: prevalence and its relationship with dyspeptic symptoms. J. Gastroenterol. Hepatol. 2004 19 : 535 40.
10. Lagerg J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med. 1999 340 : 825 31.
11. Rajendra S, Kutty K, Karim N. Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all. Dig. Dis. Sci. 2004 49 : 237 42.
12. Valle C, Broglia F, Pistorio A, Tinelli C, Perego M. Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease. Dig. Dis. Sci. 1999 44 : 1848 52.
13. Oliveria SA, Christos PJ, Talley NJ, Dannenberg AJ. Heartburn risk factors, knowledge and prevention strategies, a population-based survey of individuals with heartburn. Arch. Intern. Med. 1999 159 : 1592 8.
14. Bolin TD, Korman MG, Hansky J, Stanton R. Heartburn: community perceptions. J. Gastroenterol. Hepatol. 2000 15 : 35 9.
15. Peura DA, Malfertheiner P. Chairmen's summary: dichotomies and directions in acid-related disorders. Aliment Pharmacol. Ther. 2004 19 (Suppl. 1 77 80.
16. Gold BD. Epidemiology and management of gastro-oesophageal reflux in children. Aliment. Pharmacol. Ther. 2004 19 (Suppl. 1 22 7.
17. Pique JM, Kulich KR, Vegazoc O et al. [Burden of gastroesophageal reflux disease. Evidence from a recent methodological study in Spain.] Gastroenterol. Hepatol. 2004 27 : 300 6 (in Spanish).
18. Sontag SJ, O'Connell S, Miller TQ, Bernsen M, Seidel J. Asthmatics have more nocturnal gasping and reflux symptoms than nonasthmatics, and they are related to bedtime eating. Am. J. Gastroenterol. 2004 99 : 789 96.
19. Vaezi MF. Laryngitis and gastroesophageal reflux disease: increasing prevalence or poor diagnostic tests? Am. J. Gastroenterol. 2004 99 : 786 8.
20. Williams RB, Szczesniak MM, Maclean JC, Brake HM, Cole IE, Cook IJ. Predictors of outcome in an open label, therapeutic trial of high-dose Omeprazole in laryngitis. Am. J. Gastroenterol. 2004 99 : 777 85.
21. Modlin IM, Moss SF, Kidd M, Lye KD. Gastroesophageal reflux disease: then and now. Clin. Gastroenterol. 2004 38 : 390 402.
22. Van Roekel NB. Gastroesophageal reflux disease, tooth erosion, and prosthodontic rehabilitation: a clinical report. J. Prosthodont. 2003 12 : 255 9.
23. Loehrl TA, Smith TL. Chronic sinusitis and gastroesophageal reflux: are they related? Curr. Opin. Otolaryngol. Head Neck Surg. 2004 12 : 18 20.
24. Vaezi MF. Extraesophageal manifestations of gastroesophageal reflux disease. Clin. Cornerstone 2003 5 : 32 40.
25. Yuksekol I, Tasan Y, Ozkan M, Balkan A, Bicak M, Demirci N. [Recurrent aspiration pneumonia and Barrett's esophagus: a case report.] Tuberk Toraks. 2003 51 : 52 5 (in Turkish).
26. Lackey MA, Barth J. Gastroesophageal reflux disease: a dental concern. Gen. Dent. 2003 51 : 250 4.
27. Malagelada JR. Review article: supra-oesophageal manifestations of gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 2004 19 (Suppl. 1 43 8.
28. Carrau RL, Khidr A, Crawley JA, Hillson EM, Davis JK, Pashos CL. The impact of laryngopharyngeal reflux on patient-reported quality of life. Laryngoscope 2004 114 : 670 4.
29. Zalesska-Krecicka M, Wasko-Czopnik D, Krecicki T, Paradowski L, Zatonski M, Horobiowska M. [Laryngeal symptoms in patients with gastroesophageal reflux diseases.] Otolaryngol. Pol. 2003 57 : 819 22 (in Polish).